{"AllianceGenome": "11285", "HGNC": "11285", "MIM": "607306", "_id": "6716", "_version": 1, "accession": {"genomic": ["AB047857.1", "AEKP01018982.1", "AL133247.1", "AY884245.1", "CH471053.2", "CP068276.2", "KC876863.1", "KC876889.1", "KF456642.1", "KF456647.1", "KF456649.1", "KF456650.1", "KF456653.1", "KF495789.1", "L03843.1", "NC_000002.12", "NC_060926.1", "NG_008365.2"], "protein": ["AAA60586.1", "AAI12253.1", "AAI13642.1", "AAW56942.1", "ABQ59050.1", "BAB40419.1", "BAG38184.1", "EAX00478.1", "NP_000339.2", "P31213.2", "XP_011531371.1", "XP_011531374.1", "XP_054199524.1", "XP_054199525.1", "XP_054199526.1"], "rna": ["AK307235.1", "AK316597.1", "BC112252.1", "BC113641.1", "EF560740.1", "M74047.1", "NM_000348.4", "XM_011533069.3", "XM_011533072.3", "XM_054343549.1", "XM_054343550.1", "XM_054343551.1"], "translation": [{"protein": "ABQ59050.1", "rna": "EF560740.1"}, {"protein": "XP_054199525.1", "rna": "XM_054343550.1"}, {"protein": "XP_054199526.1", "rna": "XM_054343551.1"}, {"protein": "NP_000339.2", "rna": "NM_000348.4"}, {"protein": "XP_054199524.1", "rna": "XM_054343549.1"}, {"protein": "AAI13642.1", "rna": "BC113641.1"}, {"protein": "XP_011531374.1", "rna": "XM_011533072.3"}, {"protein": "BAG38184.1", "rna": "AK316597.1"}, {"protein": "AAA60586.1", "rna": "M74047.1"}, {"protein": "XP_011531371.1", "rna": "XM_011533069.3"}, {"protein": "AAI12253.1", "rna": "BC112252.1"}]}, "ec": "1.3.1.22", "ensembl": {"gene": "ENSG00000277893", "protein": "ENSP00000477587", "transcript": "ENST00000622030", "translation": [{"protein": "ENSP00000477587", "rna": "ENST00000622030"}], "type_of_gene": "protein_coding"}, "entrezgene": "6716", "exons": [{"cdsend": 31580900, "cdsstart": 31526195, "chr": "2", "position": [[31522479, 31526262], [31529306, 31529457], [31531370, 31531472], [31533602, 31533766], [31580619, 31580938]], "strand": -1, "transcript": "NM_000348", "txend": 31580938, "txstart": 31522479}], "exons_hg19": [{"cdsend": 31805969, "cdsstart": 31751265, "chr": "2", "position": [[31747549, 31751332], [31754376, 31754527], [31756440, 31756542], [31758672, 31758836], [31805689, 31805880], [31805880, 31806007]], "strand": -1, "transcript": "NM_000348", "txend": 31806007, "txstart": 31747549}], "generif": [{"pubmed": 11164181, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11303586, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11355945, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11381197, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11440959, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 11547131, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11571725, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11588134, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 11751447, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11845321, "text": "The expression of 5 alpha-reductase type 2 was localized to the stroma surrounding the urethra, especially along the urethral seam area in the ventral portion of the remodeling urethra."}, {"pubmed": 11847524, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11869378, "text": "despite a complete loss of function of 5alpha-reductase type 2, marked virilization is possible, most likely the result of a testosterone (T) effect during foetal life."}, {"pubmed": 11903314, "text": "role in blood pressure"}, {"pubmed": 11927504, "text": "no substantial association seen between V89L variant and risk of prostate cancer"}, {"pubmed": 12042668, "text": "5alpha-reductase 2 polymorphisms are associated with prostate cancer"}, {"pubmed": 12042668, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12100746, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12111704, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12111704, "text": "Polymorphisms within the gene are biomarkers for the development of benign prostatic hyperplasia and benign prostatic enlargement(SRD5A2)"}, {"pubmed": 12115497, "text": "DHT may play more important roles than testosterone in the regulation of androgen action in endometrial cancer and normal human endometrium, especially in the secretory phase, in which both AR and 5alpha-reductase are increased"}, {"pubmed": 12137870, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12164325, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12210487, "text": "LL genotype at codon 89 of SRD5A2 associated with poor prognosis in men with prostate cancer"}, {"pubmed": 12210487, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12370109, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12446983, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12670724, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12670724, "text": "polymorphisms of SRD5A1 and SRD5A2 genes may not be directly associated with the development of baldness or generation of different clinical phenotypes."}, {"pubmed": 12712437, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12712437, "text": "Our results do not support the hypothesis that the V89L and A49T polymorphisms in the SRD5A2 gene are related to the risk of prostate cancer"}, {"pubmed": 12738739, "text": "Loss of 5alpha-reductase type II expression is associated with metastatic prostate cancer"}, {"pubmed": 12746845, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12746845, "text": "Polymorphisms of SRD5A2 are unlikely to significantly increase susceptibility to hereditary or sporadic prostate cancer in the study populations."}, {"pubmed": 12771801, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12771801, "text": "SRD5A2 gene codes the steroid 5-reductase type II, a critical mediator of androgen action, and the V89L and A49T polymorphisms of this gene may be associated risk of prostate cancer or benign prostatic hyperplasia"}, {"pubmed": 12788885, "text": "Enhanced peripheral 5 alpha-reductase activity in PCOS."}, {"pubmed": 12815006, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12815006, "text": "The SRD5A2 (TA)(n) repeat polymorphism was not associated with androgen levels."}, {"pubmed": 12843198, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12843198, "text": "in Japanese patients, micropenis can be caused by SRD5A2 gene mutations, especially by R227Q which has been shown to retain approximately 3.2% of normal enzyme activity and appears relatively frequent in Asian populations"}, {"pubmed": 12869400, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12949937, "text": "Association of prostate cancer with reduced 5alpha-reductase enzymatic activity as result of remarkably decreased expression of the SRD5A2 gene. Implications for finasteride therapy of prostate cancer."}, {"pubmed": 12971967, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14594182, "text": "Mutational analysis revealed [in the proband] a homozygous mutation in exon 4 of SRD5A2 gene changing codon 227 from CGA (for arginine) to CAA (for glutamine)."}, {"pubmed": 14652280, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14693733, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14739525, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15061984, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15136785, "text": "Candidate gene for benign prostatic hyperplasia."}, {"pubmed": 15136785, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15201804, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15212687, "text": "Expression of SRD5A1 (5alphaR1) and SRD5A2 (5alphaR2) is elevated, and expression of AKR1C1 (20alpha-HSO), AKR1C2 (3alpha-HSO3) and AKR1C3 (3alpha-HSO2) is reduced in tumorous as compared to normal breast tissue."}, {"pubmed": 15241822, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15266301, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15326487, "text": "Various types of mutation exist in prostate cancer."}, {"pubmed": 15337247, "text": "This is the first demonstration of an alteration of 5alpha-reductase isoform 2 gene expression in X-ALD, that may be related to the steroidogenesis impairment and to the specific organ malfunction."}, {"pubmed": 15389785, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15477877, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15477877, "text": "Polymorphisms of SRD5A2 is associated with prostate cancer risk"}, {"pubmed": 15538746, "text": "5alpha-reductase type 1 (5alphaR1) immunostaining is increased and 5alpha-reductase type 2(5alphaR2) immunostaining is decreased during development of prostate cancer and there is increased expression of both in recurrent and metastatic cancers"}, {"pubmed": 15711606, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15733480, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15770495, "text": "Mutations of the steroid 5alpha-reductase type 2 (SRD5A2) gene in 46,XY subjects cause masculinization defects of varying degrees. This is the first report of a single-nucleotide insertion in the coding sequence of the SRD5A2 gene."}, {"pubmed": 16018939, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16018939, "text": "the SRD5A2 gene may play an important role in both BPH and prostate cancer"}, {"pubmed": 16029630, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16039774, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16039774, "text": "Point mutation in SRD5A2 gene, responsible for higher conversion of testosterone to DHT, seem to be more common in men with prostate cancer than men from the general population."}, {"pubmed": 16155734, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16174723, "text": "In 37 cases of more severe hypospadias we have found only two previously described mutations, one in the androgen receptor and one in the SRD5A2 gene."}, {"pubmed": 16174723, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16325991, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16487406, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16487406, "text": "SRD5A2 gene variants were associated with sperm concentration and motility, but not with epididymal and accessory sex gland markers."}, {"pubmed": 16608396, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16716118, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16736621, "text": "Exon 4 is a hot spot region of mutation within SRD5A2 in patients with hypospadias."}, {"pubmed": 16818707, "text": "The SRD5A2 mRNA expression in human prostatic tissue is 4-fold lower than normal rat."}, {"pubmed": 16821341, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16849416, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16859836, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17108148, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 17136762, "text": "5alpha-Reductase type 2 gene variant is associated with prostate cancer"}, {"pubmed": 17136762, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17220347, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17328668, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17376218, "text": "Distribution of polymorphisms in SRD5A2 and androgen receptor differed between prostate cancer low-risk population from Greenland and relatively high-risk Swedish male population."}, {"pubmed": 17376218, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17448593, "text": "Low activity of an amino acid substituted variant is assoiated with increased risk of aggressive prostatic cancer."}, {"pubmed": 17448593, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17507624, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17588204, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17609295, "text": "5alphaR deficiency in subjects without parental consanguinity and the presence of compound heterozygotic patients suggest that SRD5A2 mutations carrier frequency may be higher than previously thought"}, {"pubmed": 17669147, "text": "the number of TA repeats and the V89L variant of SRD5A2 failed to show a statistical influence on either macroscopic or microscopic prostate anatomy"}, {"pubmed": 17785571, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17823934, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 17823934, "text": "SRD5A2 V89L polymorphism may modify the prostate cancer risk conferred by polymorphism of HSD3B2."}, {"pubmed": 18000232, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18000232, "text": "The SRD5A2 Val89Leu SNP is not associated with transsexualism, refuting SRD5A2 as a candidate gene of transsexualism."}, {"pubmed": 18086758, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18097518, "text": "Identification of the R246Q mutation of the SRD5A2 gene from two unrelated Indian families possibly extends the founder gene effect in pseudohermaphroditism"}, {"pubmed": 18163429, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18258185, "text": "Our results demonstrate that the 5alphaR activities of either bDPCs or sDPCs are stronger than that of dermal fibroblasts, despite the fact that the major steroidogenic activity is attributed to 17beta-HSD rather than 5alphaR among the three cell types."}, {"pubmed": 18268111, "text": "Men with the L/L of V/L genotype with increased serum levels of DHEAS and 3alpha-diol G were positively associated with a higher risk of aggressive prostate cancer."}, {"pubmed": 18268111, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18306354, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18314109, "text": "Case Report: Identification of mutations in the SRD5A2 gene in Thai patients with male pseudohermaphroditism."}, {"pubmed": 18350250, "text": "The genetic alteration in three 46,XY infants of Mexican origin who were compound heterozygotes for SRD5A2 mutations has been identified."}, {"pubmed": 18391525, "text": "Molecular analysis of the SRD5A2 gene should be warranted in newborns with abnormal ratio before sex assignment."}, {"pubmed": 18391540, "text": "findings show all 34R mutation carrying sequences had 100% linkage to the 89L allele, contrasting normal ones with low 89L frequencies; this linkage infers a founder effect among Egyptians having G34R mutation"}, {"pubmed": 18431743, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18469342, "text": "After evaluating more than 6000 cases and 6000 controls, there is little evidence of a role for the SRD5A2 A49T variant in prostate cancer risk."}, {"pubmed": 18469342, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18483391, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18495332, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18501301, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18503826, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18566991, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 18717241, "text": "Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development."}, {"pubmed": 18722876, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18767927, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18780294, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18780294, "text": "The SRD5A2 leucine isoform appears to be acting in a dose-dependent manner as a significant disease-modifying factor in young men diagnosed with prostate cancer."}, {"pubmed": 18949357, "text": "Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search."}, {"pubmed": 19064572, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19125422, "text": "Upregulation of this enzyme enhances the cellular response to low, but not high, concentrations of testosterone in prostatic cancer, which enables prolifertion of this cancer."}, {"pubmed": 19215786, "text": "Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors."}, {"pubmed": 19215786, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19246976, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19267353, "text": "Inhibitors of this enzyme are recommended for men who have moderate-to-severe lower urinary tract symptoms and benign prostatic enlargement [REVIEW]"}, {"pubmed": 19383266, "text": "Report changes in human placental 5alpha-reductase isoenzyme expression with advancing gestation: effects of fetal sex and glucocorticoid exposure."}, {"pubmed": 19443907, "text": "Our study emphasizes that the (TA)(9) allele might confer certain prostate cancer risk but that A49T and V89L polymorphisms do not confer PC risk in South Indian men."}, {"pubmed": 19492581, "text": "p.R246Q is a common SRD5A2 mutation in 5alpha-reductase deficiency patients from the Indian subcontinent."}, {"pubmed": 19505920, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19574343, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19598235, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19760631, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19846565, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19914946, "text": "Meta-analysis and HuGE review of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19914946, "text": "systematic review and meta-analysis (1997-2007) to examine associations between two polymorphisms in the SRD5a2 gene, V89L & A49T & prostate cancer; found that prostate cancer was not associated with V89L & was probably not associated with A49T [review]"}, {"pubmed": 19926884, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19926884, "text": "polymorphisms exhibit no adverse effect on semen parameters in Estonian men"}, {"pubmed": 19956849, "text": "BASP1 and SRD5A2 are methylated in early hepatocellular carcinoma"}, {"pubmed": 19962986, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20019388, "text": "presence of the P212R mutation may constitute a founder gene effect"}, {"pubmed": 20056642, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20056642, "text": "We investigated associations between single nucleotide polymorphisms in genes HSD3B1, SRD5A1/2, and AKR1C2 and prostate cancer risk"}, {"pubmed": 20059664, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20059664, "text": "The possible associations between common polymorphisms in HSD17B3 as well as well-known V89L polymorphism in SRD5A2 and risk of hypospadias."}, {"pubmed": 20132346, "text": "a 5-alpha reductase defect should be considered in all XY newborns with ambiguous genitalia and normal plasma T secretion, whatever their geographic area or ethnic group; moreover, this defect was not linked to specific phenotype"}, {"pubmed": 20173016, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20179965, "text": "Data show that a novel homozygous point mutation of SRD5A2 gene at codon 65 in exon 1, due to a proline for alanine substitution in a Turkish family whose proband has severe undervirilization."}, {"pubmed": 20200332, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20214802, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20215396, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20215396, "text": "Single nucleotid polymorphisms in SRD5A2 do not associate with hypospadias in a Dutch population."}, {"pubmed": 20381444, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20511729, "text": "The same IVS1-2A>G mutation in the SRD5A2 gene seems to characterize all Cypriot patients with 5alphaSRD diagnosed so far."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634197, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20736251, "text": "Seven out of eight patients with 46,XY disorders of sex development had at least one variant in exon 4, and 8 of 12 (66.7%) mutations were located in exon 4."}, {"pubmed": 20800085, "text": "An interaction may occur in schizophrenia (SCZ) between SRD5A2 variants coding for the enzyme steroid 5alpha-reductase, giving rise to increased 5alpha-reductase activity in SCZ."}, {"pubmed": 20800085, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20855474, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20855474, "text": "The genetic variation of SRD5A2 is associated with circulating 3alpha-diol-3G and 3alpha-diol-17G concentrations in Chinese elderly men."}, {"pubmed": 21037542, "text": "The review provides evidence of variation in the mutational spectrum of the SRD5A2 gene leading to population-specific high prevalence of characteristic disease or phenotypic expression."}, {"pubmed": 21147889, "text": "In the largest cohort to date, we demonstrate a wide spectrum of phenotypes and biological profiles in patients with 5alpha-reductase deficiency"}, {"pubmed": 21177315, "text": "Carriers of A49T polymorphism might improve the risk of prostate cancer in higher stages (Stages III-IV), carriers of long TA repeat might decrease the risk, and 89L may not be an important risk factor."}, {"pubmed": 21218640, "text": "V89L polymorphism in SRD5A2 is not related with the prognosis of prostate cancer, but may be indirectly associated with its risk."}, {"pubmed": 21402750, "text": "SRD5A2 deficiency is more prevalent than expected in the adult female 46XY DSD population"}, {"pubmed": 21511288, "text": "polymorphism of the SRD5A2 gene is a strong determinant of hypospadias risk among children of Indian origin"}, {"pubmed": 21530059, "text": "Single nucleotide polymorphisms in the two isoforms of 5alpha-reductase, SRD5A1 and SRD5A2, are associated with lean patients with polycystic ovary syndrome."}, {"pubmed": 21540559, "text": "3 compound heterozygous mutations in the SRD5A2 gene were identified in 3 hypospadia patients. Two frameshift heterozygous mutations, c.655delT and c.755_756insT, led to a dramatic reduction in 5alpha-reductase activity"}, {"pubmed": 21557268, "text": "In androgen-stimulated and castration-recurrent prostate cancer, 5alpha-reductase-3 immunostaining was present in most epithelial cells and at similar levels, and at levels higher than observed in benign prostate."}, {"pubmed": 21627373, "text": "Polymorphisms in SRD5A2 gene is associated with benign prostate hyperplasia."}, {"pubmed": 21631525, "text": "result suggests that 46,XY DSD patient phenotypes may be influenced by SRD5A2 polymorphism genotypes. SRD5A2 gene mutations may not be as infrequent as previously considered in 46,XY DSD patients with variable degrees of external genitalia virilization"}, {"pubmed": 21676395, "text": "A statistically significant reduction of SRD5A1, SRD5A2, and CYP19A gene expression was found in the dermal papillae cells and peripheral blood mononuclear cells in idiopathic hirsutism."}, {"pubmed": 21714467, "text": "Two novel mutations of SRD5A2 were detected in these patients and their mother, which are p.Gly34fs and c.699-1G>T"}, {"pubmed": 21715084, "text": "Show positive associations of several SRD5A1 and SRD5A2 variations as independent predictors of biochemical recurrence after radical prostatectomy."}, {"pubmed": 22272144, "text": "homozygous mutation in exon 2 of SRD5A2 gene was identified in two 46,XY affected siblings raised as females."}, {"pubmed": 22362597, "text": "A missense mutation in exon 4 of SRD5A2 (resulting in amino acid substitution, E200K) has been identified in 4 sisters with 46, XY disorder of sex development; the sisters were born to consanguineous parents. [CASE REPORT]"}, {"pubmed": 22453073, "text": "Study identiflied a novel SRD5A2 mutation in a Taiwanese newborn with ambiguous genitalia."}, {"pubmed": 22486281, "text": "The 5alphaR-positive apocrine carcinomas were clinicopathologically more aggressive than 5alphaR-negative cases."}, {"pubmed": 22509838, "text": "Based on a limited selection of gene variants, no involvement of SRD5A1, SRD5A2, ESR1, ESR2 or PGR in female pattern hair loss is evident."}, {"pubmed": 22707254, "text": "The functionally relevant V89L SRD5A2 polymorphism is significantly implicated in alcohol craving in male patients during withdrawal."}, {"pubmed": 22735779, "text": "The rs13395648 TC genotype was associated with a significantly lower semen volume compared with the TT genotype."}, {"pubmed": 23044880, "text": "SRD5A2 deficiency should be included in differential diagnosis of all newborns with 46,XY disorders of sex development with normal testosterone production before gender assignment. [REVIEW]"}, {"pubmed": 23112260, "text": "A heterozygous mutation of SRD5A2 was found in a patient with 46, XY disorders of sexual development. The same mutation was found in the mother. An intronic (1-2) homozygous T>C transition was also found; both parents had a heterozygous transition."}, {"pubmed": 23277398, "text": "V89L, but not A49T, polymorphism of SRD5A2 are not likely to have a major contribution to prostate cancer development."}, {"pubmed": 23329752, "text": "study characterized clinical features and genetically analyzed the SRD5A2 gene in 3 Chinese steroid 5alpha-reductase type 2 deficiency patients; 2 compound heterozygous mutations in SRD5A2 gene were identified: p.G203S/p.R246Q in patients 1 and 2 and p.G203S/c.655delT in patient 3"}, {"pubmed": 23499746, "text": "SRD5A1 and SRD5A2 single nucleotide polymorphisms are significantly associated with the clinical characteristics of benign prostatic hyperplasia and the efficacy of benign prostatic hyperplasia treatment."}, {"pubmed": 23505265, "text": "functional variation within SRD5A2 influences, in a sex-specific way, the severity of post-traumatic stress symptoms and risk for diagnosis of PTSD"}, {"pubmed": 23664981, "text": "a novel homozygous frame-shift mutation (c.453delC)in patients with ambiguous genitalia characterized by perineo-scrotal hypospadias, bifid scrotum, clitoris like phallus, palpable testes in inguinal canal and pseudovagina"}, {"pubmed": 23729601, "text": "genetic association study in population of boys in China: Data suggest mutations in SRD5A2 [steroid-5a-reductase, alpha peptide 2] (and possibly SF1/NR5A1 [steroidogenic factor 1]; probably not AR [androgen receptor]) are associated with hypospadias."}, {"pubmed": 23867117, "text": "study suggest that SNPs in sex steroid related genes, known to affect gene expression (rs2747648 in ESR1) and enzymatic activity (Leu89Val in SRD5A2), seem to be associated with ALTs in a general population."}, {"pubmed": 23953348, "text": "Androgen-metaboliizing enzymes, 17betaHSD5 and 5alpha1 immunoreactivity was decreased in metastatic lymph nodes of breast cancers."}, {"pubmed": 24012728, "text": "Premature termination of SRD5A2 enzyme caused by insertion mutations in two unrelated microphallus patients."}, {"pubmed": 24244276, "text": "the CYP11A1, CYP17A1, HSD3B2, SRD5A2, and HSD17B6 mRNA levels in metastases were significantly lower."}, {"pubmed": 24277450, "text": "a 32% increase in intraprostatic testosterone levels was observed in the presence of the high-risk SRD5A rs2208532 polymorphism"}, {"pubmed": 24365257, "text": "SRD5A2 genotypes significantly affect breast cancer risk in the South Indian populations"}, {"pubmed": 24412121, "text": "This review discusses the 5alpha-reductase-2 deficiency syndrome and its impact on human fertility."}, {"pubmed": 24665940, "text": "This cohort study describes the phenotypic, biochemical and long-term outcome in 11 Chinese patients with 5alpha-RD2 deficiency and defines the genotypic spectrum of SRD5A2 mutations in China."}, {"pubmed": 24737579, "text": "study concludes a significant proportion of children with presumptive diagnosis of androgen insensitivity syndrome (AIS) has normal AR gene; a significant number of children with presumptive diagnosis of AIS have mutations in SRD5A2 gene and are clinically and biochemically indistinguishable from AIS"}, {"pubmed": 24810473, "text": "Expression of the genes HSD3B1, HSD17B3, and SRD5A2 was significantly increased in BPH tissues compared to normal adjacent prostate tissues."}, {"pubmed": 25310105, "text": "The SRD5A2 V89L polymorphism was not associated with the risk of prostate cancer."}, {"pubmed": 25598933, "text": "there was no significant association between SRD5A2 SNPs and the risk of prostate cancer in the Korean population"}, {"pubmed": 25700986, "text": "methylation of SRD5A2 is regulated by DNA methyltransferase 1, and inflammatory mediators such as tumor necrosis factor alpha, NF-kappaB, and IL-6 regulate DNA methyltransferase 1 expression and thereby affect SRD5A2 promoter methylation and gene expression."}, {"pubmed": 25735326, "text": "SRD5A2 gene polymorphisms are associated with the risk of benign prostatic hyperplasia but not prostate cancer."}, {"pubmed": 25974403, "text": "Manipulation of SRD5A2 activity can regulate lipogenesis in human hepatocytes in vitro."}, {"pubmed": 26092425, "text": "Results suggest that SRD5A2 controls cell migration by indirectly regulating ERK/MAPK pathway in prostate cancer cells."}, {"pubmed": 26169017, "text": "High 5alpha-reductase activity due to the polymorphism in SRD5A2 may contribute to resistance to androgen deprivation therapy."}, {"pubmed": 26174685, "text": "the genotypic distribution of 22 single nucleotide polymorphisms in SRD5A1 and SRD5A2 in a set of Spanish prostate cancer patients, were evaluated."}, {"pubmed": 26332453, "text": "In prostate cancer, increased DNA methylation of SRD5A2 and CYP11A1 related to androgen biosynthesis functions may play a role in biochemical recurrence after patients' prostatectomy"}, {"pubmed": 26345832, "text": "the V89L and TA repeat polymorphisms of SRD5A2 gene were found to have no significant associations with breast cancer"}, {"pubmed": 26453174, "text": "Diagnosis of 5alpha-reductase 2 deficiency with assessment of the SRD5A2 gene may help in appropriate gender assignment."}, {"pubmed": 26751392, "text": "Metabolic syndrome develops more frequently in testicular cancer survivors homozygous or heterozygous variant for SNP rs523349 in SRD5A2."}, {"pubmed": 26761946, "text": "p.Ala65Pro mutation in the SRD5A2 gene causes 5alphaRD2 deficiency, especially in Turkey. V89L polymorphism may also be an important factor in the development of external genitalia"}, {"pubmed": 26855069, "text": "Although 4-dione is the main source of 5alpha-dihydrotestosterone in human preadipocytes, production of this steroid by 5 alpha-reductase isoenzymes (SRD5A1, 2 and 3) mediates the inhibitory effect of both 4-dione and testosterone on preadipocyte differentiation."}, {"pubmed": 26930261, "text": "In a recent study we reported associations between ALTs and single nucleotide polymorphisms (SNPs) in the genes encoding estrogen receptor 1 (ESR1), steroid-5-alpha-reductase, type 2 (SRD5A2) and sex hormone-binding globulin (SHBG). No associations between the previously associated SNPs in the genes ESR1 and SRD5A2 and autistic-like traits could be seen in the large replication sample."}, {"pubmed": 27051040, "text": "Mutations in SRD5A2 gene were found in 46, XY DSD children with pediatric hypospadias."}, {"pubmed": 27086719, "text": "deletion of exon 2 in the SRD5A2 gene causes various degrees of genital ambiguity leading to different sex of rearing in affected family members"}, {"pubmed": 27224879, "text": "Mutations in the SRD5A2 cause a disorder of 46,XY sex development, termed 5alpha-reductase type 2 deficiency. (Review)"}, {"pubmed": 27848231, "text": "Polymorphism in the SRD5A2 gene is associated with hypospadias."}, {"pubmed": 27849622, "text": "Mutations of the SRD5A2 gene is associated with 46, XY disorders of sex development."}, {"pubmed": 28347315, "text": "Studies indicate that enhanced 5alpha-reductase activity in subjects with polycystic ovary syndrome (PCOS) was associated with insulin resistance (IR) rather than obesity."}, {"pubmed": 28397209, "text": "Chromosomal anomalies and mutations of the SRD5A2 gene are associated with hypospadias."}, {"pubmed": 28410957, "text": "rs523349 (Val89Leu), but not rs9282858, significantly associated with risk of miscarriage, mainly in the second trimester of pregnancy"}, {"pubmed": 28489754, "text": "Meta-analysis of 20 publications incorporating 30 case-control studies indicated that the SRD5A2 rs9282858 polymorphism may be a susceptible factor to prostate cancer."}, {"pubmed": 28544750, "text": "deficiency of 5-alpha reductase type 2 was considered and SRD5A2 was sequenced. This identified homozygous pathogenic variants in SRD5A2 (p. Pro212Arg), which confirmed a diagnosis of deficiency of 5-alpha reductase type 2"}, {"pubmed": 28663096, "text": "mutations of the SRD5A2 gene are the main causes of posterior hypospadias"}, {"pubmed": 28713005, "text": "This meta-analysis suggested that the V89L polymorphism definitely increases the risk of hypospadias, and the C allele is a genetic risk factor for hypospadias occurrence"}, {"pubmed": 28940538, "text": "Lack of SRD5A2 expression in the prostate induces an androgenic to oestrogenic switch in human benign prostatic tissues."}, {"pubmed": 28947209, "text": "we demonstrated that AR, 5alphaR1 and 5alphaR2 immunoreactivity in bladder urothelial carcinoma cells significantly decreased with advanced tumor grade."}, {"pubmed": 29080015, "text": "A significant positive association of mRNA expression level and a negative association of methylation level of the SRD5A2 gene with the mRNA expression levels of CYP1A1 and CYP1B1 genes in the preputial tissue of patients with hypospadias."}, {"pubmed": 29084161, "text": "The study described in this article shows that selected SRD5A1 and SRD5A2 polymorphisms can alter the levels of metabolic and hormonal parameters in patients with BPH. Special attention should be paid to the SDR5A2 rs12470143 polymorphism, which is associated with a change in lipid profile, as well as with the inheritance and incidence rate of MetS among these patients."}, {"pubmed": 29187470, "text": "Findings suggest that 5alpha-reductases (5-AR) isoenzymes could be explored as a therapeutic target for urothelial bladder cancer (UBC) with 5alpha-reductase inhibitors (5-ARI)."}, {"pubmed": 30069579, "text": "Methylation of the 5-AR 2 gene-promoter may account for low or absent expression of 5-AR 2 in adult human prostate tissues. Increased age correlates with increased 5-AR 2 gene-promoter methylation and decreased protein expression in men with BPH."}, {"pubmed": 30269266, "text": "This is the first and largest report of the clinical and molecular genetics of 5-alpha reductase deficiency from the Middle East. It shows weak genotype/phenotype correlation and significant phenotypic heterogeneity. IVS1-2A > G mutation is the most common mutation and is likely to be a founder mutation in this part of the world."}, {"pubmed": 30353958, "text": "A 5alpha-reductase polymorphism predicts circulating T and SHBG in men"}, {"pubmed": 30695888, "text": "Among the 86 children have identified 19 SRD5A2 mutation types, p.R227Q is a hotspot mutation in Chinese"}, {"pubmed": 30703436, "text": "Androgen excess involving enhanced 5alpha-reductase activity seems not due to gain-of-function variants in the gene for SRD5A2. But there are maybe more functionally relevant SRD5A2 variants in the human genome, which in theory cause 5alpha-reductase deficiency in carriers."}, {"pubmed": 30782264, "text": "SRD5A2 is associated with hypospadias, and SRD5A2 gene polymorphisms might be one of risk factors of hypospadias."}, {"pubmed": 30815925, "text": "Study demonstrated that exon 7 of the AR gene and exons 1 and 4 of the SRD5A2 gene can harbour mutations in Iranian families with 46,XY disorders of sex development with normal testicular development."}, {"pubmed": 31219235, "text": "Higher frequency mutations were identified in SRD5A2 (52%) and AR (24%) in cohort of Han Chinese patients with hypospadias. Middle or posterior hypospadias with micropenis may be significant indicators of genetic variations. Polygenic inheritance may be a rare genetic cause of hypospadias."}, {"pubmed": 31613402, "text": "5alpha-Reductase type 2 deficiency in families from an isolated Andean population in Venezuela."}, {"pubmed": 32036582, "text": "5alpha-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature."}, {"pubmed": 32536088, "text": "[Novel compound heterozygous LoF mutations in SRD5A2 may result in disorders of sex development]."}, {"pubmed": 32659769, "text": "Association of Testosterone Levels and Steroid 5-Alpha-Reductase 2 Polymorphisms with Opioid Craving."}, {"pubmed": 32669180, "text": "showed that c.680G>A(p.R227Q) and c.608G>A(p.G203D) compound heterozygous mutations existed in the SRD5A2 gene of the child. The c.680G>A mutation inherited from his father, which was a known pathogenic mutation"}, {"pubmed": 32713132, "text": "Clinical characteristics and genotype-phenotype correlations of 130 Chinese children in a high-homogeneity single-center cohort with 5alpha-reductase 2 deficiency."}, {"pubmed": 32716491, "text": "Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5alpha-Reductases."}, {"pubmed": 32784047, "text": "Molecular genetics of disorders of sex development in a highly consanguineous population."}, {"pubmed": 32917158, "text": "5alpha-reductase inhibitors impact prognosis of urothelial carcinoma."}, {"pubmed": 33054883, "text": "5-Alfa reductase type 2 (SRD5A2) gene rs523349 polymorphism is not associated with non-obstructive azoospermia in Turkish patients."}, {"pubmed": 33110062, "text": "Structure of human steroid 5alpha-reductase 2 with the anti-androgen drug finasteride."}, {"pubmed": 33368459, "text": "Exome sequencing identified compound heterozygous mutations in the SRD5A2 gene in a case of 46,XY ambiguous genitalia."}, {"pubmed": 33418075, "text": "The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies."}, {"pubmed": 33649516, "text": "The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer."}, {"pubmed": 34162032, "text": "Genome analyses and androgen quantification for an infant with 5alpha-reductase type 2 deficiency."}, {"pubmed": 34839514, "text": "[Identification of a novel variant of SRD5A2 gene in a child featuring steroid 5alpha-reductase type 2 deficiency]."}, {"pubmed": 35135181, "text": "Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD"}, {"pubmed": 35331321, "text": "Mutational analysis of compound heterozygous mutation p.Q6X/p.H232R in SRD5A2 causing 46,XY disorder of sex development."}, {"pubmed": 35700942, "text": "Clinical, Hormonal, and Genetic Characteristics of 5alpha-Reductase Type 2 Deficiency in 103 Chinese Patients."}, {"pubmed": 36153242, "text": "Fertility potential in 5alpha-reductase type 2 deficient males."}, {"pubmed": 36344974, "text": "Upregulation of mir-1199-5p is associated with reduced type 2 5-alpha reductase expression in benign prostatic hyperplasia."}, {"pubmed": 36834714, "text": "The Genotype-Phenotype Correlation in Human 5alpha-Reductase Type 2 Deficiency: Classified and Analyzed from a SRD5A2 Structural Perspective."}, {"pubmed": 37784175, "text": "Two genetic variants in the SRD5A2 gene are found to be associated with sex differences in the disease characteristics of patients with chronic hepatitis B virus infection."}, {"pubmed": 37918676, "text": "In vitro functional study of fifteen SRD5A2 variants found in Chinese patients and the relation between the SRD5A2 genotypes and phenotypes."}], "genomic_pos": {"chr": "2", "end": 31580938, "ensemblgene": "ENSG00000277893", "start": 31522480, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006694", "qualifier": "involved_in", "term": "steroid biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006702", "qualifier": "involved_in", "term": "androgen biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006706", "qualifier": "involved_in", "term": "steroid catabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007267", "pubmed": 1944596, "qualifier": "involved_in", "term": "cell-cell signaling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008209", "pubmed": 1944596, "qualifier": "involved_in", "term": "androgen metabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008584", "pubmed": 1944596, "qualifier": "involved_in", "term": "male gonad development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009410", "qualifier": "involved_in", "term": "response to xenobiotic stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0018879", "qualifier": "involved_in", "term": "biphenyl metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0018894", "qualifier": "involved_in", "term": "dibenzo-p-dioxin metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0018963", "qualifier": "involved_in", "term": "phthalate metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021766", "qualifier": "involved_in", "term": "hippocampus development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021854", "qualifier": "involved_in", "term": "hypothalamus development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030539", "qualifier": "involved_in", "term": "male genitalia development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030540", "qualifier": "involved_in", "term": "female genitalia development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0031667", "qualifier": "involved_in", "term": "response to nutrient levels"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032354", "qualifier": "involved_in", "term": "response to follicle-stimulating hormone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033574", "qualifier": "involved_in", "term": "response to testosterone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043434", "qualifier": "involved_in", "term": "response to peptide hormone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048545", "qualifier": "involved_in", "term": "response to steroid hormone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060348", "qualifier": "involved_in", "term": "bone development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0061370", "pubmed": 10898110, "qualifier": "involved_in", "term": "testosterone biosynthetic process"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043025", "qualifier": "located_in", "term": "neuronal cell body"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0070852", "qualifier": "located_in", "term": "cell body fiber"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0003865", "qualifier": "enables", "term": "3-oxo-5-alpha-steroid 4-dehydrogenase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003865", "qualifier": "enables", "term": "3-oxo-5-alpha-steroid 4-dehydrogenase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0030283", "pubmed": 10898110, "qualifier": "enables", "term": "testosterone dehydrogenase [NAD(P)+] activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0033218", "qualifier": "enables", "term": "amide binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0047751", "pubmed": 1944596, "qualifier": "enables", "term": "3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) activity"}]}, "homologene": {"genes": [[6239, 184699], [6239, 185670], [6239, 191550], [7955, 550388], [7955, 550398], [8364, 549867], [9031, 772291], [9544, 705676], [9598, 100614992], [9606, 6716], [9615, 403715], [9913, 527024], [10090, 94224], [10116, 64677]], "id": 37292}, "interpro": [{"desc": "3-oxo-5-alpha-steroid 4-dehydrogenase, C-terminal", "id": "IPR001104", "short_desc": "3-oxo-5_a-steroid_4-DH_C"}, {"desc": "3-oxo-5-alpha-steroid 4-dehydrogenase", "id": "IPR016636", "short_desc": "3-oxo-5-alpha-steroid_4-DH"}, {"desc": "3-oxo-5-alpha-steroid 4-dehydrogenase/very-long-chain enoyl-CoA reductase", "id": "IPR039357", "short_desc": "SRD5A/TECR"}], "ipi": "IPI00010651", "map_location": "2p23.1", "name": "steroid 5 alpha-reductase 2", "other_names": ["3-oxo-5-alpha-steroid 4-dehydrogenase 2", "5 alpha-SR2", "S5AR 2", "SR type 2", "steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)", "type II 5-alpha reductase"], "pantherdb": {"HGNC": "11285", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2150380", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 10090, "uniprot_kb": "Q99N99"}, {"RGD": "621480", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 10116, "uniprot_kb": "P31214"}, {"Ensembl": "ENSGALG00000010625", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 9031, "uniprot_kb": "F1NUW1"}, {"ZFIN": "ZDB-GENE-050417-182", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 7955, "uniprot_kb": "F8W397"}, {"ZFIN": "ZDB-GENE-050417-199", "ortholog_type": "O", "panther_family": "PTHR10556", "taxid": 7955, "uniprot_kb": "Q566Z4"}, {"WormBase": "WBGene00014241", "ortholog_type": "O", "panther_family": "PTHR10556", "taxid": 6239, "uniprot_kb": "Q23431"}, {"WormBase": "WBGene00008959", "ortholog_type": "O", "panther_family": "PTHR10556", "taxid": 6239, "uniprot_kb": "Q19605"}, {"WormBase": "WBGene00009635", "ortholog_type": "O", "panther_family": "PTHR10556", "taxid": 6239, "uniprot_kb": "Q20344"}], "uniprot_kb": "P31213"}, "pathway": {"humancyc": [{"id": "PWY-7305", "name": "superpathway of steroid hormone biosynthesis"}, {"id": "PWY-7455", "name": "allopregnanolone biosynthesis"}, {"id": "PWY66-378", "name": "androgen biosynthesis"}], "kegg": [{"id": "hsa00140", "name": "Steroid hormone biosynthesis - Homo sapiens (human)"}, {"id": "hsa05215", "name": "Prostate cancer - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-193048", "name": "Androgen biosynthesis"}, {"id": "R-HSA-196071", "name": "Metabolism of steroid hormones"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8957322", "name": "Metabolism of steroids"}], "wikipathways": [{"id": "WP4523", "name": "Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism"}, {"id": "WP4524", "name": "The alternative pathway of fetal androgen synthesis"}, {"id": "WP4673", "name": "Male infertility"}]}, "pdb": "7BW1", "pfam": "PF02544", "pharmgkb": "PA36113", "pharos": {"target_id": 14548, "tdl": "Tclin"}, "pir": "A49169", "prosite": "PS50244", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF256699", "relationship": "is"}, {"id": "GNF256700", "relationship": "is"}, {"id": "GNF256701", "relationship": "is"}, {"id": "GNF256702", "relationship": "is"}, {"id": "GNF256703", "relationship": "is"}, {"id": "GNF256704", "relationship": "is"}, {"id": "GNF256705", "relationship": "is"}, {"id": "GNF256706", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF039560", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF279636", "relationship": "is"}}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1", "NG_008365.2"], "protein": ["NP_000339.2", "XP_011531371.1", "XP_011531374.1", "XP_054199524.1", "XP_054199525.1", "XP_054199526.1"], "rna": ["NM_000348.4", "XM_011533069.3", "XM_011533072.3", "XM_054343549.1", "XM_054343550.1", "XM_054343551.1"], "translation": [{"protein": "XP_054199526.1", "rna": "XM_054343551.1"}, {"protein": "XP_054199525.1", "rna": "XM_054343550.1"}, {"protein": "NP_000339.2", "rna": "NM_000348.4"}, {"protein": "XP_054199524.1", "rna": "XM_054343549.1"}, {"protein": "XP_011531374.1", "rna": "XM_011533072.3"}, {"protein": "XP_011531371.1", "rna": "XM_011533069.3"}]}, "reporter": {"HG-U133_Plus_2": "206938_at", "HG-U95Av2": "565_at", "HTA-2_0": "TC02001716.hg.1", "HuEx-1_0": "2547231", "HuGene-1_1": "8051361", "HuGene-2_1": "16896237"}, "summary": "This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008].", "symbol": "SRD5A2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C0919429"}, "unigene": "Hs.458345", "uniprot": {"Swiss-Prot": "P31213"}, "wikipedia": {"url_stub": "SRD5A2"}}